Regorafenib
Tablet,Film
Coated: 40 mg
Regorafenib is a kinase inhibitor indicated for the treatment of patients with:
Metastatic colorectal cancer (CRC) who have been previously treated with fluoropyrimidine-, oxaliplatin- and irinotecan-based chemotherapy, an anti-VEGF therapy, and, if RAS-wild type, an anti-EGFR therapy.Locally advanced, unresectable or metastatic gastrointestinal stromal tumor (GIST) who have been previously treated with imatinib mesylate and sunitinib malate.